Franklin Resources Inc Mirati Therapeutics, Inc. Transaction History

Franklin Resources Inc

$343 Billion
Q4 2024

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 09, 2024	SELL	$41.99 - $62.38 $32.6 Million - $48.5 Million	-777,277 Reduced 97.01%	23,991 $1.41 Million
Q3 2023 Nov 13, 2023	BUY	$27.8 - $45.35 $4.14 Million - $6.75 Million	148,878 Added 22.82%	801,268 $34.9 Million
Q2 2023 Aug 11, 2023	BUY	$36.13 - $49.49 $794 - $1,088	22 Added 0.0%	652,390 $23.6 Million
Q1 2023 May 12, 2023	SELL	$36.54 - $54.26 $3.08 Million - $4.58 Million	-84,400 Reduced 11.46%	652,368 $24.3 Million
Q4 2022 Feb 10, 2023	SELL	$41.27 - $98.62 $29.9 Million - $71.3 Million	-723,425 Reduced 49.54%	736,768 $33.4 Million
Q3 2022 Nov 14, 2022	BUY	$59.5 - $86.7 $102,816 - $149,817	1,728 Added 0.12%	1,460,193 $102 Million
Q2 2022 Aug 11, 2022	BUY	$39.16 - $88.71 $12 Million - $27.3 Million	307,184 Added 26.68%	1,458,465 $97.9 Million
Q1 2022 May 13, 2022	SELL	$75.82 - $150.97 $8.63 Million - $17.2 Million	-113,790 Reduced 8.99%	1,151,281 $94.7 Million
Q4 2021 Feb 11, 2022	SELL	$132.01 - $190.29 $2.2 Million - $3.18 Million	-16,687 Reduced 1.3%	1,265,071 $186 Million
Q3 2021 Nov 12, 2021	BUY	$132.13 - $177.45 $5.09 Million - $6.83 Million	38,489 Added 3.1%	1,281,758 $227 Million
Q2 2021 Aug 13, 2021	BUY	$144.0 - $179.73 $36.2 Million - $45.1 Million	251,126 Added 25.31%	1,243,269 $201 Million
Q1 2021 May 13, 2021	BUY	$158.92 - $221.61 $112 Million - $156 Million	701,778 Added 241.69%	992,143 $170 Million
Q4 2020 Feb 10, 2021	BUY	$162.05 - $240.27 $12.3 Million - $18.3 Million	76,121 Added 35.53%	290,365 $63.8 Million
Q3 2020 Nov 12, 2020	SELL	$113.26 - $167.27 $10.8 Million - $15.9 Million	-94,927 Reduced 30.7%	214,244 $35.6 Million
Q1 2020 May 13, 2020	BUY	$69.78 - $116.21 $879,228 - $1.46 Million	12,600 Added 4.25%	309,171 $23.8 Million
Q4 2019 Feb 12, 2020	SELL	$70.76 - $128.86 $1.54 Million - $2.81 Million	-21,800 Reduced 6.85%	296,571 $38.2 Million
Q3 2019 Nov 14, 2019	BUY	$77.91 - $109.6 $1.9 Million - $2.68 Million	24,420 Added 8.31%	318,371 $24.8 Million
Q2 2019 Aug 14, 2019	SELL	$59.49 - $104.71 $8.99 Million - $15.8 Million	-151,200 Reduced 33.97%	293,951 $30.3 Million
Q1 2019 May 14, 2019	BUY	$43.65 - $78.95 $19.4 Million - $35.1 Million	445,151 New	445,151 $32.6 Million

Others Institutions Holding MRTX

# of Institutions

Shares Held

3.57M

Call Options Held

Put Options Held

36.6K

View Full List

About Mirati Therapeutics, Inc.

Ticker MRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,609,800
Description
Mirati Therapeutics, Inc., a clinical-stage oncology company, develops product candidates to address the genetic and immunological promoters of cancer in the United States. The company develops MRTX849, a KRAS G12C inhibitor, which is in Phase 1/2 clinical trial for treating non-small cell lung (NSCL), colorectal, pancreatic, and other cancers; ...

More about MRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Franklin Resources Inc, based on Form 13F filings with the SEC.

News

Stay updated on Franklin Resources Inc with notifications on news.

Account